Pricing Log in Create free account

GH Research PLC (GHRS) vs Oric Pharmaceuticals, Inc. (ORIC)

GH Research PLC and Oric Pharmaceuticals, Inc. are both Biotechnology companies. GH Research PLC and Oric Pharmaceuticals, Inc. are of similar size ($1.3B and $1.3B). Across the 9 metrics below, GH Research PLC leads on 7 and Oric Pharmaceuticals, Inc. on 2.

Valuation

Metric GHRS ORIC Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 3.36 3.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (5.51%) (10.93%) (33.15%)
Free cash flow yield (4.29%) (8.42%) (25.50%)

Profitability

Metric GHRS ORIC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (18.79%) (39.80%) (56.36%)
Return on assets (18.16%) (37.35%) (48.04%)
Return on invested capital 0.00% (83.77%) 0.00%

Growth

Metric GHRS ORIC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (5.33%) 19.67% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GHRS ORIC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 28.70 13.19 4.72
Net debt to EBITDA 4.65 1.95 0.96

Dividend

Metric GHRS ORIC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GHRS ORIC Biotechnology median
Market cap 1.29b 1.32b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack